Abstract :

Spatial transcriptomics, which deals with tissue architecture in genetic investigation, is an innovative technique for examining cell heterogeneity and tissue organization. This review emphasizes major approaches, include spatially resolved transcriptome methods, immunohistochemistry as well as in situ hybridization, all of which permit the mapping of RNA molecules in their native tissue environment. These methods have proven essential in achieving our understanding of biological events such as tumor evolution, progression of cancer, and cancer tumor stem cell detection. Spatial transcriptomics, the study of patterns of gene expression in space, reveals the intricate nature of the tumor microenvironment (TME) and its effect on cancer biology. Although it delivers insight on the cellular connections that underlie disease, the significance of spatial transcriptomics in multiple organs has expanded.

Although its immense potential, there are still difficulties to be conquered, particularly within the areas of analysis of data, spatial resolution, and integration with other omics data. To be able to fully comprehend the complexities of tissues biology and ailments, this review additionally tackles future potential avenues, including the necessity for greater multiplexing, enhanced resolution, and the combination of functional genomics. With this synthesis, we intend provide an extensive summary of the state of spatial transcriptomics currently and demonstrate that it possesses the potential to improve precision medicine, cancer research, and our understanding of broader biology.

---

Keywords :

Cancer, Functional Genomics, Precision Medicine., Spatial Transcriptomics, TME

---

References :

1. Williams CG, Lee HJ, Asatsuma T, Vento-Tormo R, Haque A. An introduction to spatial transcriptomics for biomedical research. Genome Medicine. 2022a Jun 27;14(1).
2. Marusyk A, Polyak K. Tumor heterogeneity: causes and consequences. Biochim Biophys Acta. 2010 Jan;1805(1):105-17. doi: 10.1016/j.bbcan.2009.11.002. Epub 2009 Nov 18. PMID: 19931353; PMCID: PMC2814927.
3. Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF, Ailles LE. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):973-8. doi: 10.1073/pnas.0610117104. Epub 2007 Jan 8. PMID: 17210912; PMCID: PMC1783424.
4. Wang Y, Wang Y, Liu B, Gao X, Li Y, Li F, Zhou H. Mapping the tumor microenvironment in clear cell renal carcinoma by single-cell transcriptome analysis. Front Genet. 2023 Jul 18;14:1207233. doi: 10.3389/fgene.2023.1207233. PMID: 37533434; PMCID: PMC10392130.
5. Grasset EM, Deshpande A, Lee JW, Cho Y, Shin SM, Coyne EM, Hernandez A, Yuan X, Zhang Z, Cimino-Mathews A, Ewald AJ, Ho WJ. Mapping the breast tumor microenvironment: proximity analysis reveals spatial relationships between macrophage subtypes and metastasis-initiating cancer cells. Oncogene. 2024 Sep;43(39):2927-2937. doi: 10.1038/s41388-024-03127-9. Epub 2024 Aug 20. PMID: 39164522.
6. Singh D, Dhiman VK, Pandey M, Dhiman VK, Sharma A, Pandey H, et al. Personalized medicine: An alternative for Cancer Treatment. Cancer Treatment and Research Communications [Internet]. 2024 Dec 20;48(42):100860. Available from: https://www.sciencedirect.com/science/article/pii/S2468294224000728
7. Madukwe JC. Overcoming drug resistance in cancer. Cell. 2023 Apr;186(8):1515–6.
8. Shaymaa AlWaheidi. Promoting cancer prevention and early diagnosis in the occupied Palestinian territory. Journal of Cancer Policy. 2022 Dec 6;35:100373–3.
9. Schott M, León-Periñán D, Splendiani E, Strenger L, Jan Robin Licha, Tancredi Massimo Pentimalli, et al. Open-ST: High-resolution spatial transcriptomics in 3D. Cell. 2024 Jun 1;39(22).
10. Heo YJ, Hwa C, Lee GH, Park JM, An JY. Integrative Multi-Omics Approaches in Cancer Research: From Biological Networks to Clinical Subtypes. Mol Cells. 2021 Jul 31;44(7):433-443. doi: 10.14348/molcells.2021.0042. PMID: 34238766; PMCID: PMC8334347.
11. Maurya R, Chug I, Vudatha V, Palma AM. Applications of spatial transcriptomics and artificial intelligence to develop integrated management of pancreatic cancer. Adv Cancer Res. 2024;163:107-136. doi: 10.1016/bs.acr.2024.06.007. Epub 2024 Jul 9. PMID: 39271261.
12. Passaro A, Al Bakir M, Hamilton EG, Diehn M, André F, Roy-Chowdhuri S, Mountzios G, Wistuba II, Swanton C, Peters S. Cancer biomarkers: Emerging trends and clinical implications for personalized treatment. Cell. 2024 Mar 28;187(7):1617-1635. doi: 10.1016/j.cell.2024.02.041. PMID: 38552610; PMCID: PMC7616034.
13. Carnevali F, Forciniti S, Onesto V, Siciliano AC, Iuele H, Grasso G, et al. Advancements in Cancer Research: 3D Models, Single‐Cell, and Live‐Cell Techniques for Better Insights. Advanced Therapeutics. 2024 Nov 9;12(22).
14. Ståhl, P. L., Salmén, F., Vickovic, S., Lundmark, A., Navarro, J. F., Magnusson, J., Giacomello, S., Asp, M., Westholm, J. O., Huss, M., Mollbrink, A., Linnarsson, S., Codeluppi, S., Borg, Å., Pontén, F., Costea, P. I., Sahlén, P., Mulder, J., Bergmann, O., … Frisén, J. (2016). Visualization and analysis of gene expression in tissue sections by spatial transcriptomics. Science (New York, N.Y.), 353(6294), 78–82. https://doi.org/10.1126/science.aaf2403
15. Jamalzadeh, S., Häkkinen, A., Andersson, N., Huhtinen, K., Laury, A., Hietanen, S., Hynninen, J., Oikkonen, J., Carpén, O., Virtanen, A., & Hautaniemi, S. (2022). QuantISH: RNA in situ hybridization image analysis framework for quantifying cell type-specific target RNA expression and variability. Laboratory Investigation; a Journal of Technical Methods and Pathology, 102(7), 753–761. https://doi.org/10.1038/s41374-022-00743-5
16. Wilkinson, D. G. (Ed.). (1998). In situ hybridization: A Practical Approach. Oxford University PressOxford. https://doi.org/10.1093/oso/9780199636594.001.0001
17. Schaeren-Wiemers, N., & Gerfin-Moser, A. (1993). A single protocol to detect transcripts of various types and expression levels in neural tissue and cultured cells: in situ hybridization using digoxigenin-labelled cRNA probes. Histochemistry, 100(6), 431–440. https://doi.org/10.1007/bf00267823
18. Madrid MA, Lo RW. Chromogenic in situ hybridization (CISH): a novel alternative in screening archival breast cancer tissue samples for HER-2/neu status. Breast Cancer Research. 2004 Jul 29;6(5).
19. Raj, A., van den Bogaard, P., Rifkin, S. A., van Oudenaarden, A., & Tyagi, S. (2008). Imaging individual mRNA molecules using multiple singly labeled probes. Nature Methods, 5(10), 877–879. https://doi.org/10.1038/nmeth.1253
20. Shakoori AR. Fluorescence In Situ Hybridization (FISH) and Its Applications. Chromosome Structure and Aberrations [Internet]. 2017 Feb 10;1(1):343–67. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC7122835/
21. Wang, F., Flanagan, J., Su, N., Wang, L.-C., Bui, S., Nielson, A., Wu, X., Vo, H.-T., Ma, X.-J., & Luo, Y. (2012). RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. The Journal of Molecular Diagnostics: JMD, 14(1), 22–29. https://doi.org/10.1016/j.jmoldx.2011.08.002
22. Vathiotis, I. A., Yang, Z., Reeves, J., Toki, M., Aung, T. N., Wong, P. F., Kluger, H., Syrigos, K. N., Warren, S., & Rimm, D. L. (2021). Models that combine transcriptomic with spatial protein information exceed the predictive value for either single modality. Npj Precision Oncology, 5(1), 1–6. https://doi.org/10.1038/s41698-021-00184-1
23. Goltsev, Y., Samusik, N., Kennedy-Darling, J., Bhate, S., Hale, M., Vazquez, G., Black, S., & Nolan, G. P. (2018). Deep profiling of mouse splenic architecture with CODEX multiplexed imaging. Cell, 174(4), 968-981.e15. https://doi.org/10.1016/j.cell.2018.07.010
24. Maniatis, S., Äijö, T., Vickovic, S., Braine, C., Kang, K., Mollbrink, A., Fagegaltier, D., Andrusivová, Ž., Saarenpää, S., Saiz-Castro, G., Cuevas, M., Watters, A., Lundeberg, J., Bonneau, R., & Phatnani, H. (2019). Spatiotemporal dynamics of molecular pathology in amyotrophic lateral sclerosis. Science (New York, N.Y.), 364(6435), 89–93. https://doi.org/10.1126/science.aav9776
25. Jackson, H. W., Fischer, J. R., Zanotelli, V. R. T., Ali, H. R., Mechera, R., Soysal, S. D., Moch, H., Muenst, S., Varga, Z., Weber, W. P., & Bodenmiller, B. (2020). The single-cell pathology landscape of breast cancer. Nature, 578(7796), 615–620. https://doi.org/10.1038/s41586-019-1876-x
26. Mirzazadeh R, Andrusivova Z, Larsson L, Newton PT, Galicia LA, Abalo XM, et al. Spatially resolved transcriptomic profiling of degraded and challenging fresh frozen samples. Nature Communications [Internet]. 2023 Jan 31;14(1):509. Available from: https://www.nature.com/articles/s41467-023-36071-5
27. Chen, K. H., Boettiger, A. N., Moffitt, J. R., Wang, S., & Zhuang, X. (2015). RNA imaging. Spatially resolved, highly multiplexed RNA profiling in single cells. Science (New York, N.Y.), 348(6233), aaa6090. https://doi.org/10.1126/science.aaa6090
28. Rodriques, S. G., Stickels, R. R., Goeva, A., Martin, C. A., Murray, E., Vanderburg, C. R., Welch, J., Chen, L. M., Chen, F., & Macosko, E. Z. (2019). Slide-seq: A scalable technology for measuring genome-wide expression at high spatial resolution. Science (New York, N.Y.), 363(6434), 1463–1467. https://doi.org/10.1126/science.aaw1219
29. Kiessling, P., & Kuppe, C. (2024). Spatial multi-omics: novel tools to study the complexity of cardiovascular diseases. Genome Medicine, 16(1). https://doi.org/10.1186/s13073-024-01282-y
30. Zhao, E., Stone, M. R., Ren, X., Guenthoer, J., Smythe, K. S., Pulliam, T., Williams, S. R., Uytingco, C. R., Taylor, S. E. B., Nghiem, P., Bielas, J. H., & Gottardo, R. (2021). Spatial transcriptomics at subspot resolution with BayesSpace. Nature Biotechnology, 39(11), 1375–1384. https://doi.org/10.1038/s41587-021-00935-2
31. Svensson, V., Teichmann, S. A., & Stegle, O. (2018). SpatialDE: identification of spatially variable genes. Nature Methods, 15(5), 343–346. https://doi.org/10.1038/nmeth.4636
32. Jin Y, Zuo Y, Li G, Liu W, Pan Y, Fan T, et al. Advances in spatial transcriptomics and its applications in cancer research. Molecular Cancer. 2024 Jun 20;23(1).
33. De Zuani M, Xue H, Park JS, Dentro SC, Seferbekova Z, Tessier J, et al. Single-cell and spatial transcriptomics analysis of non-small cell lung cancer. Nature Communications [Internet]. 2024 May 23;15(1):4388. Available from: https://www.nature.com/articles/s41467-024-48700-8
34. Wang W, Chu L, Li H, Zhang MJ, Dang K, Gao CY, et al. Spatial transcriptomics: recent developments and insights in respiratory research. Military Medical Research. 2023 Aug 17;10(1).
35. Larroquette M, Guegan JP, Besse B, Cousin S, Brunet M, Le Moulec S, et al. Spatial transcriptomics of macrophage infiltration in non-small cell lung cancer reveals determinants of sensitivity and resistance to anti-PD1/PD-L1 antibodies. Journal for ImmunoTherapy of Cancer. 2022 May;10(5):e003890.
36. Andersson A, Larsson L, Stenbeck L, Salmén F, Ehinger A, Wu SZ, et al. Spatial deconvolution of HER2-positive breast cancer delineates tumor-associated cell type interactions. Nature Communications. 2021 Oct 14;12(1).
37. Zhang Y, Gong S, Liu X. Spatial transcriptomics: a new frontier in accurate localization of breast cancer diagnosis and treatment. Frontiers in Immunology. 2024 Oct 8;15.
38. Alzahrani S, Al Doghaither H, Al‑Ghafari A. General insight into cancer: An overview of colorectal cancer (Review). Molecular and Clinical Oncology. 2021 Nov 1;15(6).
39. Liu J, Li H, Wang L, Wang S, Tang Q. Spatial transcriptome and single-cell reveal the role of nucleotide metabolism in colorectal cancer progression and tumor microenvironment. Journal of Translational Medicine. 2024 Jul 29;22(1).
40. Nowell P. The clonal evolution of tumor cell populations. Science. 1976 Oct 1;194(4260):23–8.
41. Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E, et al. Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing. New England Journal of Medicine. 2012 Mar 8;366(10):883–92.
42. Negrini S, Gorgoulis VG, Halazonetis TD. Genomic Instability — an Evolving Hallmark of Cancer. Nature Reviews Molecular Cell Biology. 2010 Mar;11(3):220–8.
43. Hanahan D, Weinberg Robert A. Hallmarks of cancer: the next Generation. Cell. 2011 Mar;144(5):646–74.
44. Valastyan S, Weinberg Robert A. Tumor Metastasis: Molecular Insights and Evolving Paradigms. Cell. 2011 Oct;147(2):275–92.
45. Thiery JP, Acloque H, Huang RYJ, Nieto MA. Epithelial-Mesenchymal Transitions in Development and Disease. Cell. 2009 Nov;139(5):871–90.
46. Wan JCM, Massie C, Garcia-Corbacho J, Mouliere F, Brenton JD, Caldas C, et al. Liquid biopsies come of age: towards implementation of circulating tumour DNA. Nature Reviews Cancer. 2017 Apr 1;17(4):223–38.
47. Sharma P, Allison JP. The future of immune checkpoint therapy. Science [Internet]. 2015 Apr 2;348(6230):56–61. Available from: https://www.science.org/doi/10.1126/science.aaa8172
48. Holohan C, Van Schaeybroeck S, Longley DB, Johnston PG. Cancer drug resistance: an evolving paradigm. Nature Reviews Cancer [Internet]. 2013 Oct 1;13(10):714–26. Available from: https://www.nature.com/articles/nrc3599.pdf
49. Batlle E, Clevers H. Cancer stem cells revisited. Nature medicine. 2017;23(10):1124–34.
50. Walcher L, Kistenmacher AK, Suo H, Kitte R, Dluczek S, Strauß A, et al. Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized Therapies. Frontiers in Immunology [Internet]. 2020 Aug 7;11(1280). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426526/
51. Lathia JD, Liu H. Overview of Cancer Stem Cells and Stemness for Community Oncologists. Targeted Oncology. 2017 Jun 30;12(4):387–99.
52. Biserova K, Jakovlevs A, Uljanovs R, Strumfa I. Cancer Stem Cells: Significance in Origin, Pathogenesis and Treatment of Glioblastoma. Cells. 2021 Mar 11;10(3):621.
53. Gatenby RA, Zhang J, Brown JS. First Strike–Second Strike Strategies in Metastatic Cancer: Lessons from the Evolutionary Dynamics of Extinction. Zenodo (CERN European Organization for Nuclear Research). 2019 Jul 10;66(19).
54. Melssen MM, Sheybani ND, Slingluff CL, Slingluff CL. Barriers to immune cell infiltration in tumors. Journal for ImmunoTherapy of Cancer [Internet]. 2023 Apr 1 [cited 2023 Nov 27];11(4):e006401–1. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124321/
55. Maffuid K, Cao Y. Decoding the Complexity of Immune–Cancer Cell Interactions: Empowering the Future of Cancer Immunotherapy. Cancers. 2023 Aug 21;15(16):4188–8.
56. Page DB, Broeckx G, Jahangir CA, Verbandt S, Gupta RR, Thagaard J, et al. Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer. The Journal of Pathology [Internet]. 2023 Aug 1 [cited 2024 Mar 3];260(5):514–32. Available from: https://pubmed.ncbi.nlm.nih.gov/37608771/
57. Xiao Y, Yu D. Tumor microenvironment as a therapeutic target in cancer. Pharmacology & Therapeutics [Internet]. 2020 Nov 28;221(107753):107753. Available from: https://www.sciencedirect.com/science/article/pii/S0163725820302849
58. Arneth B. Tumor Microenvironment. Medicina. 2019 Dec 30;56(1):15.
59. Cigir Biray Avci, Bakiye Goker Bagca, Masoud Nikanfar, Takanlou LS, Takanlou MS, Alireza Nourazarian. Tumor microenvironment and cancer metastasis: molecular mechanisms and therapeutic implications. Frontiers in Pharmacology. 2024 Nov 12;15.
60. Farc O, Cristea V. An overview of the tumor microenvironment, from cells to complex networks (Review). Experimental and Therapeutic Medicine. 2020 Nov 26;21(1).
61. Karczewski KJ, Snyder MP. Integrative omics for health and disease. Nature Reviews Genetics [Internet]. 2018 Feb 26;19(5):299–310. Available from: https://www.nature.com/articles/nrg.2018.4
62. Gidey F, Awono C. High Dimensional Data Visualization: Advances and Challenges. International Journal of Computer Applications. 2017 Mar 15;162(10):23–7.
63. Aparicio L, Bordyuh M, Blumberg AJ, Rabadan R. A Random Matrix Theory Approach to Denoise Single-Cell Data. Patterns. 2020 Jun;1(3):100035.
64. Vahabi N, Michailidis G. Unsupervised Multi-Omics Data Integration Methods: A Comprehensive Review. Frontiers in Genetics. 2022 Mar 22;13.
65. Elmarakeby HA, Hwang J, Arafeh R, Crowdis J, Gang S, Liu D, et al. Biologically informed deep neural network for prostate cancer discovery. Nature [Internet]. 2021 Oct 1;598(7880):348–52. Available from: https://www.nature.com/articles/s41586-021-03922-4

66. Shaaban S, Ji Y. Challenges of Clinical Pharmacogenomics Implementation in the Era of Precision Medicine. Medical Research Archives. 2024;12(11).
67. Vavekanand R. Data Security and Privacy in Genomics Research: A Comparative Analysis to Protect Confidentiality. Studies in Medical and Health Sciences [Internet]. 2024 May 11;1(1):23–31. Available from: https://sabapub.com/index.php/SMHS/article/view/1158

68. Ward MM. Personalized Therapeutics: A Potential Threat to Health Equity. Journal of General Internal Medicine. 2012 Feb 7;27(7):868–70.
69. Patel S, Slavin C, Rao RR. Ethical Considerations in Personalized Medicine. Ethics in Biology, Engineering and Medicine: An International Journal. 2020;11(1):89–93.
70. Bernasconi L, Şen S, Angerame L, Balyegisawa AP, Hong Yew Hui D, Hotter M, et al. Legal and ethical framework for global health information and biospecimen exchange – an international perspective. BMC Medical Ethics. 2020 Jan 21;21(1).
71. None Santoshkumar Anchoori. Designing Privacy-Preserving Data Collaboration Architectures in Modern AdTech. International Journal of Scientific Research in Computer Science Engineering and Information Technology. 2024 Dec 7;10(6):1370–81.
72. Atta L, Fan J. Computational challenges and opportunities in spatially resolved transcriptomic data analysis. Nature Communications. 2021 Sep 6;12(1).
73. Maciejewski K, Czerwinska P. Scoping Review: Methods and Applications of Spatial Transcriptomics in Tumor Research. Cancers. 2024 Sep 6;16(17):3100.